A two-day specialist congress held annually in London, gathering clinicians, researchers, and industry professionals working at the intersection of artificial intelligence and digital pathology, with a programme built around workshops, keynotes, and hands-on diagnostic application.
Digital Pathology & AI Congress Europe is an annual specialist congress held in London, bringing together professionals working in digital pathology, clinical AI, and AI-powered diagnostics. The event is now in its 13th edition, with the 2026 edition scheduled for 9 to 10 December. It is organised by a United Kingdom-based commercial publisher and hosted under the website digitalpathologyeurope.com.
The 13th edition of Digital Pathology & AI Congress Europe runs on 9 and 10 December 2026 in London. The specific venue has not been disclosed publicly as of verification. The event extends across two full days and is conducted in English. No edition theme has been announced for the 2026 edition.
December is a concentrated month for specialist health-technology gatherings ahead of the year-end pause, and this congress occupies a consistent slot in that window. Its London location positions it within a city that hosts a significant density of NHS institutions, academic medical centres, and health-technology companies, making local attendance logistically accessible for a large share of the target audience. The 13th edition confirms the event's annual rhythm without interruption.
The congress draws professionals operating at the intersection of clinical practice, research, and technology deployment in pathology and AI diagnostics. The audience profile, as indicated by the event's scope, includes the following populations:
Attendance is reported at 600 or more delegates according to the organiser. The split between clinical, research, and commercial profiles is not publicly disclosed as of verification.
The congress format combines several distinct components across its two-day programme:
The number of stages or breakout tracks is not publicly disclosed. Specific session names and confirmed speakers for the 13th edition (2026) have not been announced as of verification. Speaker data available publicly relates primarily to the 12th edition held on 10 to 11 December 2025.
The programme addresses the application of artificial intelligence and digital imaging technologies to pathology and diagnostic medicine. Core thematic areas include:
No edition-specific theme has been confirmed for the 2026 programme at the time of verification.
Self-reported by organiser (Global Engage official site) unless otherwise noted.
| Expected delegates | 600+ | Organiser figure |
| Edition number | 13 | 2026 edition |
| Duration | 2 days | 9–10 December 2026 |
| Confirmed speakers (2026) | Not disclosed | See note below |
| Approximate total speakers (all editions context) | ~137 | Third-party estimate via 10times; not verified |
| Exhibitors | Not disclosed |
A confirmed speaker list for the 13th edition has not been published as of verification. The figure of approximately 137 speakers in circulation refers to a third-party aggregator estimate and has not been independently confirmed.
The congress is best suited to clinicians, researchers, and industry practitioners who are actively working on the deployment or evaluation of digital pathology tools and AI-assisted diagnostic systems. Pathologists seeking peer exposure to current clinical AI evidence, biomedical scientists building or validating AI pipelines, and technology providers seeking direct contact with clinical buyers and researchers are the natural audience. The workshop and interactive session components favour those who come with specific questions rather than general curiosity.
Several profiles are unlikely to find sufficient value in this event. General hospital administrators or health policy professionals without a direct role in diagnostics or technology procurement will find the technical depth misaligned with their needs. AI practitioners from outside healthcare, including those working in finance, logistics, or consumer applications, will encounter a programme too clinically specific to be broadly applicable. Radiologists or imaging specialists whose work does not intersect with pathology or tissue-based diagnostics may find the subject matter too narrow. Pharmaceutical professionals focused on drug development rather than diagnostics infrastructure will find limited programmatic overlap. Finally, professionals looking for a large-scale general health-tech event with broad strategic content will find this congress more applied and domain-specific than that format.
Digital Pathology & AI Congress Europe focuses specifically on the junction of AI and tissue-based diagnostics, a narrower domain than general digital health or health-technology gatherings. The programme does not address electronic health records, telemedicine, patient engagement platforms, or health-system management. Its specialist framing is reflected in the audience composition and in the solutions showcases, which concentrate on pathology imaging, slide analysis software, and related diagnostic tools.
The presence of workshops and interactive sessions creates entry points for practitioners who are not yet at senior level, provided they have active involvement in digital pathology or clinical AI projects. The congress is not structured as a training programme or educational curriculum. Attendees without an institutional or project context in the domain are likely to find the content less actionable.
The specific venue for the 2026 edition has not been disclosed publicly as of verification. London provides a practical anchor for this event given the concentration of NHS teaching hospitals, university medical schools, and health-technology companies within and around the city. For international delegates, the city's transport infrastructure and the volume of direct air routes reduce friction. The venue address will be confirmed through the official event website as the edition approaches.
The congress is operated by a United Kingdom-based commercial publisher identified through the event's official domain and organiser communications. The organiser trades under the Global Engage name, as referenced in official site attributions. The founding year of the organisation, its full city of registration, and the size of its broader event portfolio are not publicly disclosed as of verification. The organiser is a commercial publisher rather than an industry association or professional society, which is consistent with the event's open-registration model and solutions showcase component.
Thirteen editions into an annual London programme, Digital Pathology & AI Congress Europe holds a specific position in the health-technology calendar: narrow enough in scope to attract working clinical AI practitioners, broad enough in format to bring diagnostic technology providers into direct contact with a clinical and research audience that is actively evaluating tools.
Registration is managed through the official event website at digitalpathologyeurope.com. Delegate pricing for the 13th edition (2026) is not publicly disclosed as of verification. No separate registration platform URL distinct from the main site has been identified. Access conditions, including whether the event operates on an invitation-only basis or open registration, are not confirmed in publicly available materials. Prospective attendees should consult the official website directly for current pricing and registration status.
The 2026 edition runs on 9 and 10 December in London, United Kingdom. The specific venue has not been publicly announced as of verification. The daily schedule and session timing are not available at this stage.
Delegate pricing for the 2026 edition is not publicly disclosed as of verification. Whether tiered options exist, such as reduced rates for academic or NHS-affiliated delegates, is not confirmed in available materials. The organiser website is the appropriate source for current pricing information.
No official networking or meeting-scheduling application has been confirmed for this event as of verification. The programme includes designated networking sessions and interactive formats, but the infrastructure for pre-scheduled bilateral meetings has not been disclosed.
Specific pre-congress guidance has not been published for the 2026 edition as of verification. Given the workshop format embedded in the programme, delegates working on specific digital pathology or clinical AI projects may benefit from identifying relevant sessions in advance once the full programme is released. Speaker and session announcements for the 13th edition are expected to be published on the official website ahead of December 2026.
| Official website | https://www.digitalpathologyeurope.com |
| Register | https://www.digitalpathologyeurope.com |
| Programme | not disclosed |